QRG Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.5M Sell
299,948
-21,296
-7% -$1.72M 0.19% 93
2026
Q1
$27.8M Buy
321,244
+26,816
+9% +$2.57M 0.29% 67
2025
Q4
$28.3M Buy
294,428
+23,319
+9% +$2.27M 0.31% 54
2025
Q3
$25.8M Sell
271,109
-296,158
-52% -$27.2M 0.31% 59
2025
Q2
$49.4M Buy
567,267
+43,455
+8% +$3.69M 0.43% 42
2025
Q1
$47.1M Buy
523,812
+104,050
+25% +$9.31M 0.49% 33
2024
Q4
$33.5M Buy
419,762
+21,697
+5% +$1.88M 0.35% 56
2024
Q3
$35.8M Buy
398,065
+165,077
+71% +$13.9M 0.39% 49
2024
Q2
$18.3M Buy
232,988
+2,495
+1% +$205K 0.22% 104
2024
Q1
$20.1M Buy
230,493
+53,284
+30% +$4.55M 0.26% 96
2023
Q4
$14.6M Sell
177,209
-15,182
-8% -$1.16M 0.22% 107
2023
Q3
$15.1M Buy
+192,391
New +$16.1M 0.26% 91

Other funds holding MDT

QRG Capital Management's MDT Position: Q2 2026 in Review

QRG Capital Management reduced its Medtronic (MDT) stake by 6.6% in Q2 2026, selling an estimated $1.72M and leaving 299,948 shares worth $23.5M. The position accounts for 0.19% of the portfolio, ranked #93.

QRG Capital Management first reported a position in MDT in Q3 2023 and has held it in 12 quarters since. The position peaked at $49.4M in Q2 2025. 339 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • QRG Capital Management held 299,948 shares of Medtronic worth $23.5M as of Q2 2026.
  • QRG Capital Management sold 21,296 Medtronic shares in Q2 2026, an estimated $1.72M.
  • Medtronic made up 0.19% of QRG Capital Management's portfolio in Q2 2026, its #93 holding.
  • QRG Capital Management first reported a position in Medtronic in Q3 2023 and has held it in 12 quarters since.
  • QRG Capital Management's Medtronic position peaked at $49.4M in Q2 2025.
  • 339 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.